Browse > Article
http://dx.doi.org/10.5487/TR.2012.28.2.073

Risk Assessment Principle for Engineered Nanotechnology in Food and Drug  

Hwang, Myung-Sil (Risk Analysis Research Department, National Institute of Food and Drug Safety Evaluation, Korea Food and Drug Administration)
Lee, Eun-Ji (Risk Analysis Research Department, National Institute of Food and Drug Safety Evaluation, Korea Food and Drug Administration)
Kweon, Se-Young (Risk Analysis Research Department, National Institute of Food and Drug Safety Evaluation, Korea Food and Drug Administration)
Park, Mi-Sun (Risk Analysis Research Department, National Institute of Food and Drug Safety Evaluation, Korea Food and Drug Administration)
Jeong, Ji-Yoon (Risk Analysis Research Department, National Institute of Food and Drug Safety Evaluation, Korea Food and Drug Administration)
Um, Jun-Ho (Risk Analysis Research Department, National Institute of Food and Drug Safety Evaluation, Korea Food and Drug Administration)
Kim, Sun-Ah (Risk Analysis Research Department, National Institute of Food and Drug Safety Evaluation, Korea Food and Drug Administration)
Han, Bum-Suk (Hoseo University)
Lee, Kwang-Ho (Risk Analysis Research Department, National Institute of Food and Drug Safety Evaluation, Korea Food and Drug Administration)
Yoon, Hae-Jung (Risk Analysis Research Department, National Institute of Food and Drug Safety Evaluation, Korea Food and Drug Administration)
Publication Information
Toxicological Research / v.28, no.2, 2012 , pp. 73-79 More about this Journal
Abstract
While the ability to develop nanomaterials and incorporate them into products is advancing rapidly worldwide, understanding of the potential health safety effects of nanomaterials has proceeded at a much slower pace. Since 2008, Korea Food and Drug Administration (KFDA) started an investigation to prepare "Strategic Action Plan" to evaluate safety and nano risk management associated with foods, drugs, medical devices and cosmetics using nano-scale materials. Although there are some studies related to potential risk of nanomaterials, physical-chemical characterization of nanomaterials is not clear yet and these do not offer enough information due to their limitations. Their uncertainties make it impossible to determine whether nanomaterials are actually hazardous to human. According to the above mention, we have some problems to conduct the human exposure risk assessment currently. On the other hand, uncertainty about safety may lead to polarized public debate and to businesses unwillingness for further nanotechnology investigation. Therefore, the criteria and methods to assess possible adverse effects of nanomaterials have been vigorously taken into consideration by many international organizations: the World Health Organization, the Organization for Economic and Commercial Development and the European Commission. The object of this study was to develop risk assessment principles for safety management of future nanoproducts and also to identify areas of research to strengthen risk assessment for nanomaterials. The research roadmaps which were proposed in this study will be helpful to fill up the current gaps in knowledge relevant nano risk assessment.
Keywords
Nanomaterials; Nanoproducts; Risk assessment; Research roadmap;
Citations & Related Records
연도 인용수 순위
  • Reference
1 US FDA. (2007). Nanotechnology: A report of the US Food and Drug Administration Nanotechnology task force. Available from URL: http://www.fda. gov/ScienceResearch/SpecialTopics/Nanotechnology/nanotechnologyTaskTorceReport2007.
2 WHO. (1999). IPCS environmental health criteria 210: Principles for the toxicological assessment of risks to human health from exposure to chemicals. Geneva. World health organization. Available from URL: http://www.inchem.org/documents/ehc/ehc210.html.
3 WHO. (2010). FAO/WHO Expert meeting on the application of nanotechnologies in the food and agriculture sectors: potential food safety implications meeting report
4 Woodrow wilson center. (2012). The project on emerging nanotechnologies. Accessed by 2012 01. Available from URL: http://www.nanotechproject.org/inventories/consumer/.
5 Yoon, C.S. (2007). Potential health risks and issues of nanoparticles. Biochem News, 27, 7-19.
6 Zero waste citizen center. (2010). Provision of information on nanomaterial-containing household products to consumers & survey on consumer's perception of related risks. Available from URL: http://zerowaste21.org/mkBoard/mkboard.php.
7 Lam, C.W., James, J.T., McCluskey, R. and Hunter, R.L. (2004). Pulmonary toxicity of single-wall carbon nanotubes in mice 7 and 90 days after intratracheal instillation. Toxicol. Sci., 77, 126-134.
8 Mahler, G.J., Esch, M.B., Tako, E. Southard, T.L., Archer, S.D., Glahn, R.P. and Shuler, M.L. (2012). Oral exposure to polystyrene nanoparticles affects iron absorption. Nat. Nanotechnol., 7, 246-271.
9 Ministry of Environment, Republic of Korea. (2011). Research report. Public perception about nanomaterials.
10 National nanotechnology policy center (NNPC) (2011). Nanotechnology patent (No. 4). Available from URL: http://www.nnpc.re.kr.
11 Roco, M.C. and Bainbridge, W.S. (2005). Societal implications of nanoscience and nanotechnology: Maximizing human benefit. J. Nanopart. Res., 7, 1-13.   DOI
12 Scientific committee on emerging and newly-identified health risks (SCENIHR) (2007). Opinion on the appropriateness of the risk assessment methodology in accordance with the technical guidance documents for new and existing substances for assessing the risks of nanomaterials. Available from URL: http://ec.europa.eu/health/ph_risk/risk_en.htm.
13 Stamm, H. (2011). Risk factors: Nanomaterials should be defined. Nature, 476, 399.
14 Service, R.F. (2003). American chemical society meeting. Nanomaterials show signs of toxicity. Science, 300, 243.
15 Service, R.F. (2006). Priorities needed for nano-risk research and development. Science, 314, 45.   DOI   ScienceOn
16 Silbergeld, E.K., Contreras, E.Q., Hartung, T., Hirsch, C., Honberg, H., Jachak, A.C., Jordan, W., Landsiedel, R., Morris, J., Patri, A., Pounds, J.G., de Vizcaya Ruiz, A., Shvedova, A., Tanguay, R., Tatarazako, N., van Vliet, E., Walker, N.J., Wiesner, M., Wilcox, N. and Zurlo, J. (2011). $t^{4}$ workshop report. Nanotoxicology: "The end of the beginning" - Signs on the roadmap to a strategy for assuring the safe application and use of nanomaterials. ALTEX, 28, 236-241.   DOI
17 Aschberger, K., Johnston, H.J., Stone, V., Aitken, R.J., Tran, C.L., Hankin, S.M., Peters, S.A. and Cristensen, F.M. (2010). Review of fullerene toxicity and exposure-appraisal of a human health risk assessment, based on open literature. Regul. Toxicol. Pharmacol., 58, 455-473.   DOI   ScienceOn
18 Bengt, F., Antonio, P. and Anna, A.S. (2012). Adverse effects of engineered nanomaterials; exposure, toxicology, and impact on human health. Elsevier Inc., Firth edition, ISBN 978-0-12-386940-1, pp 97-117.
19 Boxall, A.B.A., Chaudhry, Q., Sinclair, C., Jones, A., Aitken, R., Jefferson, B. and Watts, C. (2008). Current and future predicted environmental exposure to engineered nanoparticles. York: Central Science Laboratory, pp 89.
20 Chaundhry, Q., Blackburn, J., Floyd, P., George, C., Nwaogu, T., Boxall, A. and Aitken, R. (2006). A scoping study to identify gaps in environmental regulation for the products and applications of nanotechnologies. London: Department for Environment, Food and Rural Affairs.
21 Cristensen, F.M., Johnston, H.J., Stone, V., Aitken, R.J., Hankin, S., Peters, S. and Aschberger, K. (2010). Nono-silver-feasibility and challenges for human health risk assessment based on open literature. Nanotoxicology, 4, 284-295.   DOI   ScienceOn
22 Cristensen, F.M., Johnston, H.J., Stone, V., Aitken, R.J., Hankin, S., Peters, S. and Aschberger, K. (2011). Nono-$TiO_{2}$-feasibility and challenges for human health risk assessment based on open literature. Nanotoxicology, 5, 110-124.   DOI   ScienceOn
23 EFSA; European Food Safety Authority. (2009). The potential risks arising from nanoscience and nanotechnologies on food and feed safety (EFSA-Q-2007-124a). The EFSA Journal, 958, 1-39.